loadpatents
Patent applications and USPTO patent grants for IQ Therapeutics B.V..The latest application filed is for "combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins".
Patent | Date |
---|---|
Combination Antibodies For The Treatment And Prevention Of Disease Caused By Bacillus Anthracis And Related Bacteria And Their Toxins App 20110129460 - Groen; Herman | 2011-06-02 |
Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof App 20110059098 - Groen; Herman ;   et al. | 2011-03-10 |
Methods of producing stable B-lymphocytes Grant 7,807,415 - Groen , et al. October 5, 2 | 2010-10-05 |
Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof Grant 7,658,925 - Groen , et al. February 9, 2 | 2010-02-09 |
NCAGE Code | H2DS0 | IQ THERAPEUTICS B.V. |
CAGE Code | H2DS0 | IQ THERAPEUTICS B.V. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.